Severe atypical HUS caused by CFH S1191L-case presentation and review of treatment options

Pediatric Nephrology

Volumn 25, Issue 1, 2010, Pages 97-104

  De, Sudarsana ^a   Waters, Aoife M ^b   Segal, Audrey O ^a   Trautmann, Agnes ^c   Harvey, Elizabeth A ^a,d   Licht, Christoph ^a,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Atypical hemolytic uremic syndrome; Eculizumab; Plasma therapy

Indexed keywords

COMPLEMENT FACTOR H; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE; THROMBOCYTE ANTIBODY;

ADOLESCENT; AMINO ACID SUBSTITUTION; ANAMNESIS; ANEMIA; ARTICLE; CASE REPORT; CAUSAL ATTRIBUTION; DISEASE DURATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FAILURE; PERITONEAL DIALYSIS; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RETICULOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE;

BLOOD COMPONENT TRANSFUSION; COMBINED MODALITY THERAPY; COMPLEMENT FACTOR H; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MUTATION; PERITONEAL DIALYSIS; PLASMA; PLASMAPHERESIS; PREDNISONE; RECURRENCE;

EID: 76749165686     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1306-7     Document Type: Article

References (50)

1. C Gasser E Gautier A Steck RE Siebenmann R Oechslin 1955 Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 85 905 909 1:STN:280:DyaG28%2Fis1SntA%3D%3D 13274004
2. PF Zipfel J Misselwitz C Licht C Skerka 2006 The role of defective complement control in hemolytic uremic syndrome Semin Thromb Hemost 32 146 154 10.1055/s-2006-939770 1:CAS:528:DC%2BD28Xkt1KrtLY%3D 16575689
3. C Loirat M Noris V Fremeaux-Bacchi 2008 Complement and the atypical hemolytic uremic syndrome in children Pediatr Nephrol 10.1007/s00467-008-0872-4
4. TS Jokiranta PF Zipfel V Fremeaux-Bacchi CM Taylor TJ Goodship M Noris 2007 Where next with atypical hemolytic uremic syndrome? Mol Immunol 44 3889 3900 10.1016/j.molimm.2007.06.003 1:CAS:528:DC%2BD2sXpsl2htrk%3D 17768107 (Pubitemid 47337120)
5. SR de Cordoba EG de Jorge 2008 Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H Clin Exp Immunol 151 1 13 18081690
6. PF Zipfel M Edey S Heinen M Jozsi H Richter J Misselwitz B Hoppe D Routledge L Strain AE Hughes JA Goodship C Licht TH Goodship C Skerka 2007 Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome PLoS Genet 3 e41 10.1371/journal.pgen. 0030041 17367211 (Pubitemid 46535756)
7. S Heinen A Hartmann N Lauer U Wiehl HM Dahse S Schirmer K Gropp T Enghardt R Wallich S Halbich M Mihlan U Schlotzer-Schrehardt PF Zipfel C Skerka 2009 Factor H related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation Blood 10.1182/blood-2009-02-205641 19528535
8. V Fremeaux-Bacchi MA Dragon-Durey J Blouin C Vigneau D Kuypers B Boudailliez C Loirat E Rondeau WH Fridman 2004 Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J Med Genet 41 e84 10.1136/jmg.2004.019083 1:STN:280:DC%2BD2czgvFyjug%3D%3D 15173250
9. D Kavanagh EJ Kemp E Mayland RJ Winney JS Duffield G Warwick A Richards R Ward JA Goodship TH Goodship 2005 Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome J Am Soc Nephrol 16 2150 2155 10.1681/ASN.2005010103 1:CAS:528:DC%2BD2MXms1egsL4%3D 15917334 (Pubitemid 41716447)
10. M Noris S Brioschi J Caprioli M Todeschini E Bresin F Porrati S Gamba G Remuzzi 2003 Familial haemolytic uraemic syndrome and an MCP mutation Lancet 362 1542 1547 10.1016/S0140-6736(03)14742-3 1:CAS:528:DC%2BD3sXovVWlsrs%3D 14615110 (Pubitemid 37410193)
11. A Richards EJ Kemp MK Liszewski JA Goodship AK Lampe R Decorte MH Muslumanoglu S Kavukcu G Filler Y Pirson LS Wen JP Atkinson TH Goodship 2003 Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome Proc Natl Acad Sci USA 100 12966 12971 10.1073/pnas.2135497100 1:CAS:528:DC%2BD3sXoslKmsrs%3D 14566051 (Pubitemid 37340009)
12. E Goicoechea de Jorge CL Harris J Esparza-Gordillo L Carreras EA Arranz CA Garrido M Lopez-Trascasa P Sanchez-Corral BP Morgan S Rodriguez de Cordoba 2007 Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome Proc Natl Acad Sci USA 104 240 245 10.1073/pnas.0603420103 1:CAS:528:DC%2BD2sXjt1Ohsg%3D%3D 17182750 (Pubitemid 46068016)
13. V Fremeaux-Bacchi EC Miller MK Liszewski L Strain J Blouin AL Brown N Moghal BS Kaplan RA Weiss K Lhotta G Kapur T Mattoo H Nivet W Wong S Gie B Hurault de Ligny M Fischbach R Gupta R Hauhart V Meunier C Loirat MA Dragon-Durey WH Fridman BJ Janssen TH Goodship JP Atkinson 2008 Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome Blood 112 4948 4952 10.1182/blood-2008-01-133702 1:CAS:528:DC%2BD1cXhsFWms7zF 18796626
14. MC Pickering HT Cook 2008 Translational mini-review series on complement factor H: Renal diseases associated with complement factor H: novel insights from humans and animals Clin Exp Immunol 151 210 230 1:CAS:528: DC%2BD1cXitVWntL0%3D 18190458
15. M Jozsi C Licht S Strobel SL Zipfel H Richter S Heinen PF Zipfel C Skerka 2008 Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency Blood 111 1512 1514 10.1182/blood-2007-09-109876 1:CAS:528:DC%2BD1cXhvFejurY%3D 18006700 (Pubitemid 351213440)
16. M Jozsi S Strobel HM Dahse WS Liu PF Hoyer M Oppermann C Skerka PF Zipfel 2007 Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome Blood 110 1516 1518 10.1182/blood-2007-02- 071472 1:CAS:528:DC%2BD2sXhtVSgsb3P 17495132 (Pubitemid 47443967)
17. G Ariceta N Besbas S Johnson D Karpman D Landau C Licht C Loirat C Pecoraro CM Taylor N Van de Kar J Vandewalle LB Zimmerhackl 2009 Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome Pediatr Nephrol 24 687 696 10.1007/s00467-008-0964-1 18800230
18. J Caprioli M Noris S Brioschi G Pianetti F Castelletti P Bettinaglio C Mele E Bresin L Cassis S Gamba F Porrati S Bucchioni G Monteferrante CJ Fang MK Liszewski D Kavanagh JP Atkinson G Remuzzi 2006 Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 108 1267 1279 10.1182/blood-2005-10-007252 1:CAS:528: DC%2BD28Xot1ymtbk%3D 16621965 (Pubitemid 44232024)
19. LB Zimmerhackl J Scheiring F Prufer CM Taylor C Loirat 2007 Renal transplantation in HUS patients with disorders of complement regulation Pediatr Nephrol 22 10 16 10.1007/s00467-006-0210-7 17058051 (Pubitemid 46138353)
20. C Loirat V Fremeaux-Bacchi 2008 Hemolytic uremic syndrome recurrence after renal transplantation Pediatr Transplant 12 619 629 10.1111/j.1399-3046. 2008.00910.x 1:CAS:528:DC%2BD1cXhtFSltbvM 18482212
21. MA Dragon-Durey C Blanc F Marliot C Loirat J Blouin C Sautes-Fridman WH Fridman V Fremeaux-Bacchi 2009 The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome J Med Genet 46 447 450 10.1136/jmg.2008. 064766 1:CAS:528:DC%2BD1MXpslOqu7c%3D 19435718
22. S Heinen M Jozsi A Hartmann M Noris G Remuzzi C Skerka PF Zipfel 2007 Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells J Am Soc Nephrol 18 506 514 10.1681/ASN.2006091069 1:CAS:528:DC%2BD2sXit12ju78%3D 17229916 (Pubitemid 46193316)
23. R Martinez-Barricarte G Pianetti R Gautard J Misselwitz L Strain V Fremeaux-Bacchi C Skerka PF Zipfel T Goodship M Noris G Remuzzi SR de Cordoba 2008 The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome J Am Soc Nephrol 19 639 646 10.1681/ASN.2007080923 1:CAS:528:DC%2BD1cXktVamt7k%3D 18235085 (Pubitemid 351355408)
24. KH Olie S Florquin JW Groothoff R Verlaak L Strain TH Goodship JJ Weening JC Davin 2004 Atypical relapse of hemolytic uremic syndrome after transplantation Pediatr Nephrol 19 1173 1176 10.1007/s00467-004-1565-2 15300478 (Pubitemid 39317527)
25. KH Olie TH Goodship R Verlaak S Florquin JW Groothoff L Strain JJ Weening JC Davin 2005 Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir Am J Kidney Dis 45 e12 e15 10.1053/j.ajkd.2004.09.012 15696434 (Pubitemid 40038036)
26. JC Davin L Strain TH Goodship 2008 Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation Pediatr Nephrol 23 1517 1521 10.1007/s00467-008-0833-y 18483746
27. AL Lapeyraque E Wagner V Phan MJ Clermont A Merouani V Fremeaux-Bacchi TH Goodship P Robitaille 2008 Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations Pediatr Nephrol 23 1363 1366 10.1007/s00467-008-0803-4 18425537
28. A Richards MR Buddles RL Donne BS Kaplan E Kirk MC Venning CL Tielemans JA Goodship TH Goodship 2001 Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition Am J Hum Genet 68 485 490 10.1086/318203 1:CAS:528:DC%2BD3MXhtl2lsLY%3D 11170896 (Pubitemid 32147817)
29. JM Saland P Ruggenenti G Remuzzi 2009 Liver-kidney transplantation to cure atypical hemolytic uremic syndrome J Am Soc Nephrol 20 940 949 10.1681/ASN.2008080906 1:CAS:528:DC%2BD1MXlvFKqsbg%3D 19092117
30. A Hill SJ Richards P Hillmen 2007 Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria Br J Haematol 137 181 192 10.1111/j.1365-2141.2007.06554.x 1:CAS:528: DC%2BD2sXmtVGrsb0%3D 17408457 (Pubitemid 46537635)
31. P Hillmen C Hall JC Marsh M Elebute MP Bombara BE Petro MJ Cullen SJ Richards SA Rollins CF Mojcik RP Rother 2004 Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria N Engl J Med 350 552 559 10.1056/NEJMoa031688 1:CAS:528:DC%2BD2cXhtVGhtbY%3D 14762182 (Pubitemid 38160785)
32. P Hillmen NS Young J Schubert RA Brodsky G Socie P Muus A Roth J Szer MO Elebute R Nakamura P Browne AM Risitano A Hill H Schrezenmeier CL Fu J Maciejewski SA Rollins CF Mojcik RP Rother L Luzzatto 2006 The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria N Engl J Med 355 1233 1243 10.1056/NEJMoa061648 1:CAS:528:DC%2BD28XpvFKgt7k%3D 16990386 (Pubitemid 44427447)
33. RA Gruppo RP Rother 2009 Eculizumab for congenital atypical hemolytic-uremic syndrome N Engl J Med 360 544 546 10.1056/NEJMc0809959 1:CAS:528:DC%2BD1MXht1aiurw%3D 19179329
34. J Nurnberger O Witzke A Opazo Saez U Vester HA Baba A Kribben LB Zimmerhackl AR Janecke M Nagel M Kirschfink 2009 Eculizumab for atypical hemolytic-uremic syndrome N Engl J Med 360 542 544 10.1056/NEJMc0808527 19179328
35. G Remuzzi P Ruggenenti D Codazzi M Noris J Caprioli G Locatelli B Gridelli 2002 Combined kidney and liver transplantation for familial haemolytic uraemic syndrome Lancet 359 1671 1672 10.1016/S0140-6736(02)08560-4 12020532 (Pubitemid 34518531)
36. HI Cheong BS Lee HG Kang H Hahn KS Suh IS Ha Y Choi 2004 Attempted treatment of factor H deficiency by liver transplantation Pediatr Nephrol 19 454 458 10.1007/s00467-003-1371-2 14986080 (Pubitemid 38477414)
37. MA Dragon-Durey V Fremeaux-Bacchi C Loirat J Blouin P Niaudet G Deschenes P Coppo W Herman Fridman L Weiss 2004 Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases J Am Soc Nephrol 15 787 795 10.1097/01.ASN.0000115702.28859.A7 1:CAS:528:DC%2BD2cXhtlShu7w%3D 14978182 (Pubitemid 38294810)
38. G Filler S Radhakrishnan L Strain A Hill G Knoll TH Goodship 2004 Challenges in the management of infantile factor H associated hemolytic uremic syndrome Pediatr Nephrol 19 908 911 15206027
39. MA Dragon-Durey C Loirat S Cloarec MA Macher J Blouin H Nivet L Weiss WH Fridman V Fremeaux-Bacchi 2005 Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome J Am Soc Nephrol 16 555 563 10.1681/ASN.2004050380 1:CAS:528:DC%2BD2MXhvVCkt7g%3D 15590760 (Pubitemid 41725154)
40. C Licht A Weyersberg S Heinen L Stapenhorst J Devenge B Beck R Waldherr M Kirschfink PF Zipfel B Hoppe 2005 Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15 Am J Kidney Dis 45 415 421 10.1053/j.ajkd.2004.10.018 1:CAS:528:DC%2BD2MXit1yitLk%3D 15685522 (Pubitemid 40431070)
41. S Nathanson V Fremeaux-Bacchi G Deschenes 2001 Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency Pediatr Nephrol 16 554 556 10.1007/s004670100609 1:STN:280:DC%2BD38%2FitFyhtQ%3D%3D 11465803 (Pubitemid 32600159)
42. S Nathanson T Ulinski V Fremeaux-Bacchi G Deschenes 2006 Secondary failure of plasma therapy in factor H deficiency Pediatr Nephrol 21 1769 1771 10.1007/s00467-006-0237-9 16909242 (Pubitemid 44390844)
43. G Remuzzi P Ruggenenti M Colledan B Gridelli A Bertani P Bettinaglio S Bucchioni A Sonzogni E Bonanomi V Sonzogni JL Platt N Perico M Noris 2005 Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation Am J Transplant 5 1146 1150 10.1111/j.1600-6143.2005.00783.x 15816899 (Pubitemid 40571267)
44. JM Saland SH Emre BL Shneider C Benchimol S Ames JS Bromberg G Remuzzi L Strain TH Goodship 2006 Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation Am J Transplant 6 1948 1952 10.1111/j.1600-6143.2006.01375.x 1:STN:280:DC%2BD28vms1ahsg%3D%3D 16889549 (Pubitemid 44024968)
45. HY Cho BS Lee KC Moon IS Ha HI Cheong Y Choi 2007 Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate Pediatr Nephrol 22 874 880 10.1007/s00467-007-0438-x 17295030 (Pubitemid 46629624)
46. JC Davin KH Olie R Verlaak F Horuz S Florquin JJ Weening JW Groothoff L Strain TH Goodship 2006 Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment Am J Kidney Dis 47 e27 e30 10.1053/j.ajkd.2005.11.007 16431247 (Pubitemid 43121349)
47. H Jalanko S Peltonen A Koskinen J Puntila H Isoniemi C Holmberg A Pinomaki E Armstrong A Koivusalo E Tukiainen H Makisalo J Saland G Remuzzi S de Cordoba R Lassila S Meri TS Jokiranta 2008 Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H Am J Transplant 8 216 221 1:STN:280:DC%2BD1c%2FhslCmug%3D%3D 17973958
48. JM Saland BL Shneider JS Bromberg PA Shi SC Ward MS Magid C Benchimol MG Seikaly SH Emre E Bresin G Remuzzi 2009 Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome Clin J Am Soc Nephrol 4 201 206 10.2215/CJN.02170508 19005013
49. SK Sethi DD Marie-Agnes N Thaker P Hari A Bagga 2009 Hemolytic uremic syndrome due to homozygous factor H deficiency Clin Exp Nephrol 10.1007/s10157-009-0205-3 19568827
50. T Watt B Warshaw HM Katzenstein 2009 Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin Pediatr Blood Cancer 53 90 91 10.1002/pbc.21951 19301397